Protagonist Therapeutics Inc (PTGX)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | 1,118.41 | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 0.00 | 0.00 | 0.00 | 1,118.41 | 0.00 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= — + — – —
= 0.00
Protagonist Therapeutics Inc's cash conversion cycle experienced a significant increase from 0 days on December 31, 2020, to 1,118.41 days on December 31, 2021. This sharp rise indicates that the company took longer to convert its investments in inventory back into cash during that period. However, it managed to bring the cash conversion cycle back to 0 days in the subsequent years, suggesting an improvement in managing its working capital efficiently. A lower cash conversion cycle is generally favorable as it signifies quicker cash turnover, potentially indicating enhanced liquidity and operational efficiency within the organization.
Peer comparison
Dec 31, 2024